| Srinivasa R. Movva, M.d.pc | |
|
37 E Washington Ave Atlantic Highlands NJ 07716-1327 | |
| (732) 291-3430 | |
| (732) 291-5659 |
| Full Name | Srinivasa R. Movva, M.d.pc |
|---|---|
| Speciality | Internal Medicine |
| Location | 37 E Washington Ave, Atlantic Highlands, New Jersey |
| Authorized Official Name and Position | Patricia Adams (OFFICE MANAGER) |
| Authorized Official Contact | 7322913430 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Srinivasa R. Movva, M.d.pc 37 E Washington Ave Atlantic Highlands NJ 07716-1327 Ph: (732) 291-3430 | Srinivasa R. Movva, M.d.pc 37 E Washington Ave Atlantic Highlands NJ 07716-1327 Ph: (732) 291-3430 |
| NPI Number | 1114140365 |
|---|---|
| Provider Enumeration Date | 04/10/2007 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 5991761553 |
|---|---|
| Medicare Enrollment ID | O20041206000289 |
News Archive
A study featured in the November issue of the Journal of Thoracic Oncology confirms the success of a simple questionnaire designed to identify patients at high risk of lung cancer. Initiated in 2001, the current study confirmed 18 cases of cancer of the original 430 patients who qualified as high risk after completing a five-minute questionnaire
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
Walking and thinking at the same time can be especially difficult for persons who've suffered concussions, and scientists hope to use that multitasking challenge - measured by a simple radar system - to quickly screen individuals who may have suffered brain injuries.
In anticipation of next week's 2011 World Health Summit in Berlin, Germany, Neeraj Mistry, managing director of the Global Network for Neglected Tropical Disease, recaps gains in the treatment and prevention of neglected tropical diseases (NTDs) around the world through the commitment of the U.S., the U.K. and other G8 countries and makes the case for a global NTD initiative in the network's "End the Neglect" blog.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114140365 | NPI | - | NPPES |
| 7704305 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MA06591900 (New Jersey) | Primary |
| Provider Name | Srinivasa R Movva |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1699720508 PECOS PAC ID: 7618933276 Enrollment ID: I20041208000034 |
News Archive
A study featured in the November issue of the Journal of Thoracic Oncology confirms the success of a simple questionnaire designed to identify patients at high risk of lung cancer. Initiated in 2001, the current study confirmed 18 cases of cancer of the original 430 patients who qualified as high risk after completing a five-minute questionnaire
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
Walking and thinking at the same time can be especially difficult for persons who've suffered concussions, and scientists hope to use that multitasking challenge - measured by a simple radar system - to quickly screen individuals who may have suffered brain injuries.
In anticipation of next week's 2011 World Health Summit in Berlin, Germany, Neeraj Mistry, managing director of the Global Network for Neglected Tropical Disease, recaps gains in the treatment and prevention of neglected tropical diseases (NTDs) around the world through the commitment of the U.S., the U.K. and other G8 countries and makes the case for a global NTD initiative in the network's "End the Neglect" blog.
› Verified 5 days ago
| Provider Name | Kathleen E Hemschoot |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891132684 PECOS PAC ID: 8224270145 Enrollment ID: I20130806000340 |
News Archive
A study featured in the November issue of the Journal of Thoracic Oncology confirms the success of a simple questionnaire designed to identify patients at high risk of lung cancer. Initiated in 2001, the current study confirmed 18 cases of cancer of the original 430 patients who qualified as high risk after completing a five-minute questionnaire
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
Walking and thinking at the same time can be especially difficult for persons who've suffered concussions, and scientists hope to use that multitasking challenge - measured by a simple radar system - to quickly screen individuals who may have suffered brain injuries.
In anticipation of next week's 2011 World Health Summit in Berlin, Germany, Neeraj Mistry, managing director of the Global Network for Neglected Tropical Disease, recaps gains in the treatment and prevention of neglected tropical diseases (NTDs) around the world through the commitment of the U.S., the U.K. and other G8 countries and makes the case for a global NTD initiative in the network's "End the Neglect" blog.
› Verified 5 days ago
News Archive
A study featured in the November issue of the Journal of Thoracic Oncology confirms the success of a simple questionnaire designed to identify patients at high risk of lung cancer. Initiated in 2001, the current study confirmed 18 cases of cancer of the original 430 patients who qualified as high risk after completing a five-minute questionnaire
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
Walking and thinking at the same time can be especially difficult for persons who've suffered concussions, and scientists hope to use that multitasking challenge - measured by a simple radar system - to quickly screen individuals who may have suffered brain injuries.
In anticipation of next week's 2011 World Health Summit in Berlin, Germany, Neeraj Mistry, managing director of the Global Network for Neglected Tropical Disease, recaps gains in the treatment and prevention of neglected tropical diseases (NTDs) around the world through the commitment of the U.S., the U.K. and other G8 countries and makes the case for a global NTD initiative in the network's "End the Neglect" blog.
› Verified 5 days ago
Eastpointe Medical Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2391 Highway 36, Atlantic Highlands, NJ 07716 Phone: 732-872-6595 Fax: 732-872-1508 | |
Atlantic Highlands Medical Associates, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1012 Route 36, Atlantic Highlands, NJ 07716 Phone: 732-291-3865 |